ARTICLE | Company News
Cevec, Vakzine Project deal
January 7, 2013 8:00 AM UTC
Vakzine granted Cevec exclusive, worldwide rights to develop and commercialize Vakzine's human cytomegalovirus (CMV) dense body technology. Vakzine will be responsible for project management services....